149 related articles for article (PubMed ID: 16319331)
1. Respiratory insufficiency and limb muscle weakness in adults with Pompe's disease.
Pellegrini N; Laforet P; Orlikowski D; Pellegrini M; Caillaud C; Eymard B; Raphael JC; Lofaso F
Eur Respir J; 2005 Dec; 26(6):1024-31. PubMed ID: 16319331
[TBL] [Abstract][Full Text] [Related]
2. [A retrospective study of six patients with late-onset Pompe disease].
Saux A; Laforet P; Pagès AM; Figarella-Branger D; Pellissier JF; Pagès M; Labauge P
Rev Neurol (Paris); 2008 Apr; 164(4):336-42. PubMed ID: 18439925
[TBL] [Abstract][Full Text] [Related]
3. Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients.
Hagemans ML; Winkel LP; Van Doorn PA; Hop WJ; Loonen MC; Reuser AJ; Van der Ploeg AT
Brain; 2005 Mar; 128(Pt 3):671-7. PubMed ID: 15659425
[TBL] [Abstract][Full Text] [Related]
4. [Pompe's disease. Part I: pathogenesis and clinical features].
Illés Z; Trauninger A
Ideggyogy Sz; 2009 Jul; 62(7-8):231-43. PubMed ID: 19685701
[TBL] [Abstract][Full Text] [Related]
5. [Enzyme replacement therapy in Pompe's disease].
Merk T; Wibmer T; Schumann C; Krüger S
Med Klin (Munich); 2007 Jul; 102(7):570-3. PubMed ID: 17634875
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of respiratory insufficiency due to adult acid maltase deficiency with noninvasive positive pressure ventilation.
Puruckherr M; Pooyan P; Girish MR; Byrd RP; Roy TM
Sleep Med; 2004 Jul; 5(4):379-81. PubMed ID: 15222995
[TBL] [Abstract][Full Text] [Related]
7. Clinical features of late-onset Pompe disease: a prospective cohort study.
Wokke JH; Escolar DM; Pestronk A; Jaffe KM; Carter GT; van den Berg LH; Florence JM; Mayhew J; Skrinar A; Corzo D; Laforet P
Muscle Nerve; 2008 Oct; 38(4):1236-45. PubMed ID: 18816591
[TBL] [Abstract][Full Text] [Related]
8. A randomized study of alglucosidase alfa in late-onset Pompe's disease.
van der Ploeg AT; Clemens PR; Corzo D; Escolar DM; Florence J; Groeneveld GJ; Herson S; Kishnani PS; Laforet P; Lake SL; Lange DJ; Leshner RT; Mayhew JE; Morgan C; Nozaki K; Park DJ; Pestronk A; Rosenbloom B; Skrinar A; van Capelle CI; van der Beek NA; Wasserstein M; Zivkovic SA
N Engl J Med; 2010 Apr; 362(15):1396-406. PubMed ID: 20393176
[TBL] [Abstract][Full Text] [Related]
9. [Clinical manifestations, course and outcome of enzyme replacement therapy in Hungarian patients with Pompe's disease].
Bereznai B; Trauninger A; György I; Szakszon K; Almássy Z; Pál E; Herczegfalvi A; Várdi Visy K; Illés Z; Molnár MJ
Orv Hetil; 2011 Sep; 152(39):1569-75. PubMed ID: 21920843
[TBL] [Abstract][Full Text] [Related]
10. Assessment of ventilatory function in patients with neuromuscular disease.
Rochester DF; Esau SA
Clin Chest Med; 1994 Dec; 15(4):751-63. PubMed ID: 7867289
[TBL] [Abstract][Full Text] [Related]
11. [Glycogenesis Type II (M. Pompe). Selective failure of the respiratory musculature--a rare first symptom].
Burghaus L; Liu W; Neuen-Jacob E; Gempel K; Haupt WF
Nervenarzt; 2006 Feb; 77(2):181-2, 185-6. PubMed ID: 16228159
[TBL] [Abstract][Full Text] [Related]
12. [Respiratory distress in infants with Pompe's disease].
Khémiri M; Zayani M; Bou Yahya O; Zouari S; Ben Mansour F; Caillaud C; Khaldi F; Barsaoui S
Tunis Med; 2008 Jun; 86(6):612-4. PubMed ID: 19216463
[No Abstract] [Full Text] [Related]
13. Rate of disease progression during long-term follow-up of patients with late-onset Pompe disease.
Van der Beek NA; Hagemans ML; Reuser AJ; Hop WC; Van der Ploeg AT; Van Doorn PA; Wokke JH
Neuromuscul Disord; 2009 Feb; 19(2):113-7. PubMed ID: 19084399
[TBL] [Abstract][Full Text] [Related]
14. Respiratory failure in Pompe disease: treatment with noninvasive ventilation.
Mellies U; Stehling F; Dohna-Schwake C; Ragette R; Teschler H; Voit T
Neurology; 2005 Apr; 64(8):1465-7. PubMed ID: 15851748
[TBL] [Abstract][Full Text] [Related]
15. Large variation in effects during 10 years of enzyme therapy in adults with Pompe disease.
Harlaar L; Hogrel JY; Perniconi B; Kruijshaar ME; Rizopoulos D; Taouagh N; Canal A; Brusse E; van Doorn PA; van der Ploeg AT; Laforêt P; van der Beek NAME
Neurology; 2019 Nov; 93(19):e1756-e1767. PubMed ID: 31619483
[TBL] [Abstract][Full Text] [Related]
16. Clinical predictors of mechanical ventilation in Guillain-Barré syndrome.
Paul BS; Bhatia R; Prasad K; Padma MV; Tripathi M; Singh MB
Neurol India; 2012; 60(2):150-3. PubMed ID: 22626694
[TBL] [Abstract][Full Text] [Related]
17. Enzyme replacement therapy in late-onset Pompe's disease: a three-year follow-up.
Winkel LP; Van den Hout JM; Kamphoven JH; Disseldorp JA; Remmerswaal M; Arts WF; Loonen MC; Vulto AG; Van Doorn PA; De Jong G; Hop W; Smit GP; Shapira SK; Boer MA; van Diggelen OP; Reuser AJ; Van der Ploeg AT
Ann Neurol; 2004 Apr; 55(4):495-502. PubMed ID: 15048888
[TBL] [Abstract][Full Text] [Related]
18. [A case report of anesthesia for a child with Pompe's disease (glycogen storage disease type II)].
Sakakibara M; Teramoto Y; Aoyama T; Takahashi T; Hara M; Maseki M; Yamaguchi S; Nakata J
Masui; 2009 Feb; 58(2):219-22. PubMed ID: 19227183
[TBL] [Abstract][Full Text] [Related]
19. Late onset Pompe disease: clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients.
Müller-Felber W; Horvath R; Gempel K; Podskarbi T; Shin Y; Pongratz D; Walter MC; Baethmann M; Schlotter-Weigel B; Lochmüller H; Schoser B
Neuromuscul Disord; 2007 Oct; 17(9-10):698-706. PubMed ID: 17643989
[TBL] [Abstract][Full Text] [Related]
20. British Thoracic Society guideline for respiratory management of children with neuromuscular weakness.
Hull J; Aniapravan R; Chan E; Chatwin M; Forton J; Gallagher J; Gibson N; Gordon J; Hughes I; McCulloch R; Russell RR; Simonds A
Thorax; 2012 Jul; 67 Suppl 1():i1-40. PubMed ID: 22730428
[No Abstract] [Full Text] [Related]
[Next] [New Search]
